New HIV vaccine with a 97% antibody response rate in phase I human trials
The title seems to over-promise.<p>> ...the vaccine successfully stimulated the production of the rare immune cells needed to generate antibodies against HIV in 97 percent of participants.<p>This is not the same as creating a 97% antibody response.<p>The article goes on to say that it's part of a mutli-step process to create immunity, so it seems this initial shot is not enough.<p>This needs more clarity from someone with expertise in the field.